2024 South Carolina HIV, STD and Viral Hepatitis Conference: Roadmap to Success: Strengthening Communities Through Collaboration

South Carolina HIV, STD and Viral Hepatitis Conference
October 23 & 24, 2024
Columbia Metropolitan Convention Center
1101 Lincoln Street
Columbia, South Carolina 29201

To register for the conference online, please visit www.midcarolinaahec.org.

To register for the conference via mail, please follow the instructions on the conference website, www.schiv-stdconference.org.

Conference Flyer: Here

ACPE Activity Announcement: Here

Registration Fees:

TIMELINE	SINGLE DAY REGISTRATION	FULL CONFERENCE (BOTH DAYS)
Late Registration Deadline: after October 11	$205	$395
On-site Registration Deadline: after October 11	$245	$470
Student Registration* Deadline: September 13	$60	$120

*Students will be required to submit a scanned copy of their school ID (with photo) along with their registration, and MUST present their ID at registration table on-site.

Important Information:

- If you are pursuing ACPE Pharmacy credit, please add $15 to your total.

- Please note ther is a $10 convenience fee for paying online.

- Please view the registration website for more information.

The SC HIV, STD and Viral Hepatitis Conference is designed for nurse practitioners, physician assistants, nurses, other clinicians, HIV/STD/Viral Hepatitis educators, social workers, case managers, public health professionals, pharmacists, other service providers, teachers, students, people living with HIV/AIDS and other interested community members. The mission for this interdisciplinary conference is to provide opportunities for professionals and community members to engage in dialogue and share past successes, discuss current practices and interventions, as well as address emerging issues and trends.

A total of 6 of the concurrent sessions are ACPE-accredited for pharmacists, and pharmacists may claim a maximum of 6.0 live contact hours (0.6 CEUs) of application and knowledge-based continuing pharmacy education. Please see below to view the details of each session accredited for pharmacists!

Date: Oct 23, 2024 10:45 AM - Oct 24, 2024 12:55 PM

CE Hours

6.00

CE Units

0.600

Activity Type

Knowledge-Based and Application-Based

Target Audience(s)

Pharmacists

Accreditation(s)

The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

Requirements for CE Credit

Participants must sign in upon arrival and have attendance verified.

To claim credit for this activity, participants must complete the online program evaluation and must update their accounts to properly reflect their month/day of birth and correct NABP e-Profile ID. To register with NABP or look up your NABP e-Profile ID, please click on the CPE Monitor logo below to be directed to their site.

Credit that is claimed greater than 60 days from the date of the program will be automatically rejected by the CPE Monitor. Claiming credit within 30 days of the live program will ensure that any issues with transmission to the CPE Monitor can be rectified in advance of the 60-day deadline. If you would like a paper statement of credit, you may print an individual statement or a transcript from your NABP e-Profile.

Wed, Oct 23, 2024

Pre-exposure Prophylaxis Provided in the Emergency Department: Clinician Perspectives

At the completion of this activity, the participant will be able to:

Identify key risk factors for HIV and their prevalence in the Emergency Department (ED)
Discuss the role PrEP pharmacotherapy plays in HIV prevention
Review different scenarios for the implementation of PrEP in the ED
Examine the current perspectives of clinicians regarding the utilization of PrEP in the ED

Speaker(s)/Author(s)

Ava Roth, DO
Emergency Medicine PGY2, Prisma Health- Greenville

Activity Number

0062-9999-24-152-L02-P

Date: 10/23/24

Time: 10:45 AM - 11:45 AM

CE Hours

1.00

Potential Indicators of Decreased Consumer Engagement in HIV PrEP Telehealth

At the completion of this activity, the participant will be able to:

Discuss indicators of non-responsive consumers enrolled in PrEP services through a telehealth program
Explore implications of non-responsive consumers enrolled in PrEP services through a telehealth program
Identify strategies to address consumers' barriers to sustained PrEP telehealth engagement

Speaker(s)/Author(s)

Kenric Ware, PharmD, MBA, AAHIVP
Pharmacist | Board of Directors Chairperson, Joseph H. Neal Health Collaborative

Activity Number

0062-9999-24-157-L02-P

Date: 10/23/24

Time: 11:55 AM - 12:55 PM

CE Hours

1.00

HIV Update: 2024

At the completion of this activity, the participant will be able to:

Discuss the current status of the global HIV epidemic
Summarize the recent guideline updates from 2023-2024
Review new data on medications for the treatment and prevention of HIV
Explain the most significant HIV research advancements over the past year

Speaker(s)/Author(s)

Sharon Weissman, MD
Clinical Professor of Medicine, University of South Carolina School of Medicine

Activity Number

0062-9999-24-154-L02-P

Date: 10/23/24

Time: 02:50 PM - 03:50 PM

CE Hours

1.00

Gamechanger! DoxyPEP Use to Prevent STI

At the completion of this activity, the participant will be able to:

Evaluate the efficacy of DoxyPEP in preventing STIs
Identify DoxyPEP and HIV PrEP prescribing strategies for eligible patients
Discuss the benefits and harms of DoxyPEP for STI preventionr

Speaker(s)/Author(s)

Marco Tori, MD, MSc
Medical Consultant, SC Dept of Health, LCDR, US Public Health Service, CDC CEFO

Activity Number

0062-9999-24-155-L01-P

Date: 10/23/24

Time: 04:00 PM - 05:00 PM

CE Hours

1.00

Thu, Oct 24, 2024

Antiretroviral Therapy (ART) for Heavily Treatment Experienced (HTE) Patients or Multidrug Resistant HIV

At the completion of this activity, the participant will be able to:

Compare and contrast mechanisms of action of injectable ART
Evaluate HIV genotype results for the utilization of injectable ART in HTE patients
Discuss recent literature regarding injectable ART within the HTE population
Apply acquired knowledge to a patient case

Speaker(s)/Author(s)

Caroline Derrick, PharmD, BCPS, AAHIVP
Infectious Diseases Ambulatory Pharmacy Supervisor, USC School of Medicine, Department of Internal Medicine, Prisma Health-Midlands

Activity Number

0062-9999-24-153-L02-P

Date: 10/24/24

Time: 10:45 AM - 11:45 AM

CE Hours

1.00

HCV Treatment Update 2024

Please note, that the date will show up on your CPE transcript as the 25th instead of 26th.

At the completion of this activity, the participant will be able to:

Discuss the updated Hepatitis C screening and testing recommendations
Review the simplified HCV treatment algorithm
Discuss treatment options for patients with HIV/HCV co-infection, compensated and decompensated cirrhosis

Speaker(s)/Author(s)

Divya Ahuja, MD, MRCP (London)
Associate Professor of Clinical Internal Medicine, Prisma Health -University of South Carolina, School of Medicine (USC SOM); Principal Investigator, South Carolina HIV/AIDS Training Center, USC SOM; Medical Director, Immunology Center, Prisma Health

Activity Number

0062-9999-24-156-L01-P

Date: 10/24/24

Time: 11:55 AM - 12:55 PM

CE Hours

1.00